Literature DB >> 16210616

Protein kinase C-theta is an early survival factor required for differentiation of effector CD8+ T cells.

Rina Barouch-Bentov1, Edward E Lemmens, Junru Hu, Edith M Janssen, Nathalie M Droin, Jianxun Song, Stephen P Schoenberger, Amnon Altman.   

Abstract

CD8(+) T cells are crucial for host defense against invading pathogens and malignancies. However, relatively little is known about intracellular signaling events that control the genetic program of their activation and differentiation. Using CD8(+) T cells from TCR-transgenic mice crossed to protein kinase C-theta (PKCtheta)-deficient mice, we report that PKCtheta is not required for Ag-induced CD8(+) T cell proliferation, but is important for T cell survival and differentiation into functional, cytokine-producing CTLs. Ag-stimulated PKCtheta(-/-) T cells underwent accelerated apoptosis associated with deregulated expression of Bcl-2 family proteins and displayed reduced activation of ERKs and JNKs. Some defects in the function of PKCtheta(-/-) T cells (poor survival and reduced Bcl-2 and Bcl-x(L) expression, CTL activity, and IFN-gamma expression) were partially or fully restored by coculture with wild-type T cells or by addition of exogenous IL-2, whereas others (increased Bim(EL) expression and TNF-alpha production) were not. These findings indicate that PKCtheta, although not essential for initial Ag-induced proliferation, nevertheless plays an important role in promoting and extending T cell survival, thereby enabling the complete genetic program of effector CD8(+) differentiation. The requirement for PKCtheta in different types of T cell-dependent responses may, therefore, depend on the overall strength of signaling by the TCR and costimulatory receptors and may reflect, in addition to its previously established role in activation, an important, hitherto unappreciated, role in T cell survival.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16210616     DOI: 10.4049/jimmunol.175.8.5126

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  28 in total

Review 1.  PKC-θ is a drug target for prevention of T cell-mediated autoimmunity and allograft rejection.

Authors:  Myung-Ja Kwon; Ruiqing Wang; Jian Ma; Zuoming Sun
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2010-12       Impact factor: 2.895

Review 2.  TCR signaling requirements for activating T cells and for generating memory.

Authors:  Dietmar Zehn; Carolyn King; Michael J Bevan; Ed Palmer
Journal:  Cell Mol Life Sci       Date:  2012-04-19       Impact factor: 9.261

3.  GWAS analysis using interspecific backcross progenies reveals superior blue catfish alleles responsible for strong resistance against enteric septicemia of catfish.

Authors:  Suxu Tan; Tao Zhou; Wenwen Wang; Yulin Jin; Xiaozhu Wang; Xin Geng; Jian Luo; Zihao Yuan; Yujia Yang; Huitong Shi; Dongya Gao; Rex Dunham; Zhanjiang Liu
Journal:  Mol Genet Genomics       Date:  2018-05-08       Impact factor: 3.291

4.  Protective Toxoplasma gondii-specific T-cell responses require T-cell-specific expression of protein kinase C-theta.

Authors:  Gopala Nishanth; Monika Sakowicz-Burkiewicz; Ulrike Händel; Stefanie Kliche; Xiaoqian Wang; Michael Naumann; Martina Deckert; Dirk Schlüter
Journal:  Infect Immun       Date:  2010-05-24       Impact factor: 3.441

Review 5.  The yin and yang of protein kinase C-theta (PKCθ): a novel drug target for selective immunosuppression.

Authors:  Elizabeth Yan Zhang; Kok-Fai Kong; Amnon Altman
Journal:  Adv Pharmacol       Date:  2013

Review 6.  PKC-θ function at the immunological synapse: prospects for therapeutic targeting.

Authors:  Alexandra Zanin-Zhorov; Michael L Dustin; Bruce R Blazar
Journal:  Trends Immunol       Date:  2011-07-04       Impact factor: 16.687

7.  A critical role for protein kinase C-theta-mediated T cell survival in cardiac allograft rejection.

Authors:  Santhakumar Manicassamy; Dengping Yin; Zheng Zhang; Luciana L Molinero; Marisa-Luisa Alegre; Zuoming Sun
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

8.  PKCtheta is required for alloreactivity and GVHD but not for immune responses toward leukemia and infection in mice.

Authors:  Javier O Valenzuela; Cristina Iclozan; Mohammad S Hossain; Martin Prlic; Emily Hopewell; Crystina C Bronk; Junmei Wang; Esteban Celis; Robert W Engelman; Bruce R Blazar; Michael J Bevan; Edmund K Waller; Xue-Zhong Yu; Amer A Beg
Journal:  J Clin Invest       Date:  2009-11-09       Impact factor: 14.808

9.  Aggregation of spectrin and PKCtheta is an early hallmark of fludarabine/mitoxantrone/dexamethasone-induced apoptosis in Jurkat T and HL60 cells.

Authors:  Patrycja M Dubielecka; Michał Grzybek; Adam Kolondra; Bozena Jaźwiec; Anna Draga; Paulina Aleksandrowicz; Monika Kołodziejczyk; Anna Serwotka; Barbara Dolińska-Krajewska; Jerzy Warchoł; Kazimierz Kuliczkowski; Aleksander F Sikorski
Journal:  Mol Cell Biochem       Date:  2010-01-08       Impact factor: 3.396

10.  Novel antileukemic compound ingenol 3-angelate inhibits T cell apoptosis by activating protein kinase Ctheta.

Authors:  Wing-Yiu Lee; Peter Hampson; Lydia Coulthard; Farrah Ali; Mike Salmon; Janet M Lord; Dagmar Scheel-Toellner
Journal:  J Biol Chem       Date:  2010-05-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.